ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Form 6-K — Oct 22, 2026
Ascentage Pharma announced that on October 22, 2026 its trustee purchased 200,000 existing shares on-market for HK$5,740,622 (approximately HK$28.70 per share) to satisfy RSUs under the company's 2022 RSU Scheme. The purchased shares represent approximately 0.05% of total issued shares, bringing cumulative trustee on-market purchases under the scheme to 3,115,000 shares.
Key figures
- Purchased shares
- 200000
- Total consideration hkd
- 5740622
- Percent of issued shares
- approximately 0.05%
- Average price per share hkd
- approximately HK$28.70
- Cumulative trustee purchases
- 3115000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.